Bio-Com International

Bio-Com International, a biotech commercial-development consultancy, provides expert advisory services for translating emerging innovative advancements from the bench to the marketplace. To build & sustain its clients' competitive advantage, Bio-Com assists with risk/reward assessment & decision making. The firm also evaluates the economic impact of proprietary technologies for all phases of the intellectual property life cycle. Programs entail: • Conduct strategic business roadmapping: tech/market gap analysis of new opps • Deploy rigorous financial analyses driving value-based negotiations & decisions • Optimize R&D / product dev. resource allocation by analyzing capital budgeting / investments as Real Options • Build winning product & corp. strategies by employing discovery-driven planning & customer development • Provide forward-thinking market info, research & business intelligence • Assess & mitigate potential patent infringement, transactional & operational risks Bio-Com offers formidable financial & commercial capabilities plus technical/IP expertise. A key differentiator stems from its cross-functional BIOSCIENCE-IP-BUSINESS experience. NPV-driven quantitative tools are central to the firm's sweet spot: decision-analysis & strategy-development. Projects include evaluating the commercial potential of: • Molecular diagnostics (mDx) & next generation sequencing (NGS) platforms • Genomics-guided drug discovery & development tools • CDx-stratified targeted therapeutics aka personalized / precision medicine